T1	Outcomes 1019 1037	severe visual loss
T2	Outcomes 1336 1393	Fluorescein angiographic growth of classic and occult CNV
T3	Outcomes 1432 1460	temporary growth retardation
T4	Outcomes 1696 1714	severe visual loss
